Video

#Biomarkers #Listicle #Multiomics #Video

New listicle: How biomarkers are reducing risk in drug discovery

Watch this DDW listicle exploring how biomarkers are reducing risk in drug discovery and clinical trials, sponsored by Olink. As drug development becomes increasingly complex, smarter decisions depend on having the right biological data at the right time. In this video, hosted by Drug Discovery World (DDW) and… Read More

#News

#Drug discovery #Peptides #Reagents #Video

Video: Where chemistry meets biology and products meet services

Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. Biosynth manufacture and source a vast range of chemical and biochemical products and provide a full range of products… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Video

Video: Insights into structure and sequence activity 

Signals Inventa is a next-generation data management system for the analysis of scientific results. PerkinElmer has released a video that explains how this platform works.   The video shares how Signals Inventa provides a faster way to help chemists gain insights into structure and sequence activity relationships… Read More

#News

#Assay #Bioscience #Drug development #Kinetics #Video

Re-energise your kinase discovery programme

Using Promega’s NanoBRET technology, scientists at Aurelia Bioscience have implemented intracellular kinase assays designed to study the interaction of compounds on kinase targets in intact living cells. Advantages of this technique include examination of compound binding to target kinases at physiological ATP concentrations, expression of full-length kinase target… Read More

#Videos

#Assay #Bioscience #Biotechnology #Drug development #Kinetics #Research #Screening #Video

NanoBRET technology enables the study of the interaction of compounds

Aurelia Bioscience is a pre-clinical contract research organisation specialising in bioassay development, pharmacological profiling and compound screening. Scientists at Aurelia Bioscience have experience developing new and innovative bio-assays for different target classes using technologies to deliver client projects in a timely, efficient and cost-effective manner. Using Promega’s NanoBRET… Read More

#News #Videos